The mission of InClinica is to apply in-depth experience and expertise in clinical research and drug development to lead clients’ compounds and devices toward regulatory approval.

InClinica has experience across all phases of clinical development, with particular strength assisting small to mid-sized companies that are entering first-in-human trials and Phase 2 studies.